BRAIDWELL LP

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1920938 STAMFORD, CT

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,755,416

-$1,366,518 QoQ

Shares Held

183,822

-32.5% QoQ

Ownership

0.118%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#49

of 266 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRAIDWELL LP holds $115,632,817 across 4 Drug Manufacturers - Specialty & Generic names. KNSA ranks #4 (10.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	336,171	$56,658,260
2	BIOA	BioAge Labs, Inc.	1,033,129	$25,321,991
3	EOLS	Evolus, Inc.	3,155,209	$21,897,150
4	KNSA	Kiniksa Pharmaceuticals International, plc This page	183,822	$11,755,416

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,755,416	183,822	-32.5%	Shares	Sole	2026-08-14
2026-03-31	$13,121,934	272,522	-13.2%	Shares	Sole	2026-05-15
2025-12-31	$12,945,198	313,823	-51.2%	Shares	Sole	2026-02-17
2025-09-30	$24,974,679	643,180	-41.7%	Shares	Sole	2025-11-14
2025-06-30	$30,508,388	1,102,580	-43.8%	Shares	Sole	2025-08-14
2025-03-31	$43,596,208	1,962,909	-43.1%	Shares	Sole	2025-05-15
2024-12-31	$68,289,401	3,452,447	+19.3%	Shares	Sole	2025-02-14
2024-09-30	$72,333,879	2,894,513	+40.6%	Shares	Sole	2024-11-14
2024-06-30	$38,428,517	2,058,303	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.